CARE Ratings Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹164 Cr +20.6% YoYSee revenue, profit and what management said. You are viewing Q3 FY24.
CR

CARE Ratings Ltd

Q3 FY24Capital Markets

CARE Ratings Q3 FY24 earnings call: Revenue & Margins

Q3 FY24 investor presentation: what the company reported on revenue, margins and capex.

Revenue
₹79Cr
−17.7% QoQ
Net profit
₹24Cr
−33.3% QoQ
Margin
30%
−13 pp QoQ

Based on CARE Ratings Ltd's Q3 FY24 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

Price₹1,617
Market cap₹5.0K Cr
P/E28.3

The short version

Standalone Total Operating Income (TOI) for Q3FY24: Rs. 66.68 Cr, up 22% YoY (Page 16, 14, 2). Quarter (Q3 FY24) Financials - Standalone:.

From CARE Ratings Ltd's Q3 FY24 earnings-call transcript · updated 25 Sept 2026.

Revenue & Sales Performance

  • Standalone Total Operating Income (TOI) for Q3FY24: Rs. 66.68 Cr, up 22% YoY (Page 16, 14, 2).
  • Consolidated Total Operating Income for Q3FY24: Rs. 78.68 Cr, up 27% YoY (Page 16).
  • Standalone Profit After Tax for Q3FY24: Rs. 22.23 Cr, up 4% YoY (Page 16, 14, 2).
  • Consolidated Profit After Tax for Q3FY24: Rs. 23.92 Cr, up 47% YoY (Page 16).
  • EBITDA margin for standalone Q3FY24: 41%; for consolidated: 30% (Page 16, 14).

2 more points from CARE Ratings Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what CARE Ratings Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • New project announcements slowed to Rs 11.6 lakh crore in 9M FY24, down from Rs 22.2 lakh crore in 9M FY23 (Page 11).
  • Capacity utilization in manufacturing sector decreased seasonally to 73.6% in Q1 FY24 from 76.3% in Q4 FY23 but remained higher than the previous year (Page 11).
  • Centre’s capital expenditure (capex) is budgeted to rise to 22.2% of expenditure in FY24 compared to 17.4% in FY23 (Page 10).

2 more points from CARE Ratings Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Capital Markets

Ranked on what management guided this quarter

Guidance-ranked
1BSE
Rev 2Mar 3
Rev 2Mar 3
3
Rev 2Mar 3
4
Rev 2Mar 3
5
Rev 2Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what CARE Ratings Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what CARE Ratings Ltd said on order book & pipeline — free account, 30 seconds.

CARE Ratings Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

CARE Ratings Ltd Q3 FY24 results — key figures

CARE Ratings Ltd Q3 FY24 reported results vs year-ago quarter, ₹ crore
₹ CrQ3 FY24Q2 FY24QoQ
Revenue7996-17.7%
Operating profit (EBITDA)2342-45.2%
Operating margin30%43%-13 pp
Profit before tax3450-32%
Net profit (PAT)2436-33.3%
EPS (₹)7.8811.81-33.3%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹164 Cr, net profit ₹72 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

CARE Ratings Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were CARE Ratings Ltd Q3 FY24 results?

Standalone Total Operating Income (TOI) for Q3FY24: Rs. 66.68 Cr, up 22% YoY (Page 16, 14, 2). Quarter (Q3 FY24) Financials - Standalone:.

What is CARE Ratings Ltd share price analysis?

CARE Ratings Ltd currently shows a neutral. The stock trades at a P/E of 28.3 with a market cap of ₹5,026 Cr. Investors should review the full earnings analysis for detailed insights.

Is CARE Ratings Ltd planning capital expenditure?

New project announcements slowed to Rs 11.6 lakh crore in 9M FY24, down from Rs 22.2 lakh crore in 9M FY23 (Page 11).

Keep CARE Ratings Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.